Angina Market: Epidemiology, Size, Share, Analysis and Forecast till (2023-2033)

The newly published report by IMARC Group has recently released a report titled "𝐀𝐧𝐠𝐢𝐧𝐚 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 𝐨𝐟 𝐄𝐩𝐢𝐝𝐞𝐦𝐢𝐨𝐥𝐨𝐠𝐲, 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐓𝐫𝐞𝐧𝐝𝐬, 𝐒𝐢𝐳𝐞, 𝐒𝐡𝐚𝐫𝐞, 𝐚𝐧𝐝 𝐅𝐮𝐭𝐮𝐫𝐞 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 (𝟐𝟎𝟐𝟑-𝟐𝟎𝟑𝟑)" that presents a comprehensive assessment of the angina market. The report provides an extensive overview of the latest market trends, growth prospects, investment opportunities, and industry outlook, as well as an in-depth analysis of the disease landscape, market size, and growth trends.

Furthermore, the report offers an analysis of competitors, regional markets, and recent advancements in the global market. It also sheds light on crucial segments and market drivers, along with challenges faced by industry players. This report is a valuable resource for stakeholders who want to gain valuable insights into the angina market.

Angina is a medical condition characterized by chest pain that develops when the heart muscle doesn't receive enough blood flow and oxygen. Some of the symptoms of this ailment include shortness of breath, dizziness, fatigue, sweating, nausea, etc.

The pain or discomfort is triggered by physical activity, emotional stress, exposure to cold weather, or after a heavy meal and tends to go away with rest. Diagnosing angina involves a medical history and physical examination to evaluate symptoms, risk factors, and a family history of heart disease.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐚 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.imarcgroup.com/angina-market/requestsample

Market Trend:

The increasing cases of coronary artery diseases, in which the arteries supplying blood to the heart muscle are blocked or narrowed on account of the buildup of plaque, are primarily augmenting the angina market. Additionally, the elevating prevalence of several risk factors, such as coronary artery spasms, arrhythmias, aortic valve stenosis, hypertrophic cardiomyopathy, anemia, emotional stress, etc., is further propelling the market growth.

Besides this, the rising adoption of various medications, including beta-blockers, calcium channel blockers, nitroglycerin, etc., for minimizing blood pressure and enhancing the heart's energy metabolism is acting as another significant growth-inducing factor.

Moreover, the escalating demand for transcutaneous electrical nerve stimulation (TENS), which involves delivering a small electrical current to the nerves to reduce pain and discomfort associated with the ailment, is also contributing to the market growth.

Apart from this, the introduction of several improved drug delivery systems, including implantable drug delivery devices and targeted drug delivery systems, to enhance the effectiveness of anti-anginal drugs is projected to fuel the angina market over the forecasted period.

Report Period:

Base Year: 2022
Historical Period: 2017-2022
Market Forecast: 2023-2033

Countries Included:

United States
Germany
France
United Kingdom
Italy
Spain
Japan

Analysis Covered Across Each Country

Historical, current, and future epidemiology scenario
Historical, current, and future performance of the angina market
Historical, current, and future performance of various therapeutic categories in the market
Sales of various drugs across the angina market
Reimbursement scenario in the market

In-market and pipeline drugs
In-Market Drugs

Drug Overview
Mechanism of Action
Regulatory Status
Clinical Trial Results
Drug Uptake and Market Performance

Late-Stage Pipeline Drugs

Drug Overview
Mechanism of Action
Regulatory Status
Clinical Trial Results
Regulatory Status

𝐀𝐬𝐤 𝐚𝐧 𝐀𝐧𝐚𝐥𝐲𝐬𝐭 𝐟𝐨𝐫 𝐑𝐞𝐩𝐨𝐫𝐭 𝐂𝐮𝐬𝐭𝐨𝐦𝐢𝐳𝐚𝐭𝐢𝐨𝐧 𝐰𝐢𝐭𝐡 𝐓𝐎𝐂 & 𝐋𝐢𝐬𝐭 𝐨𝐟 𝐟𝐢𝐠𝐮𝐫𝐞𝐬: https://www.imarcgroup.com/angina-market

𝐊𝐞𝐲 𝐐𝐮𝐞𝐬𝐭𝐢𝐨𝐧𝐬 𝐀𝐧𝐬𝐰𝐞𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭:

How has the angina market performed so far and how will it perform in the coming years?
What are the markets shares of various therapeutic segments in 2022 and how are they expected to perform till 2033?
What was the country-wise size of the angina market across the seven major markets in 2022 and what will it look like in 2033?
What is the growth rate of the angina market across the seven major markets and what will be the expected growth over the next ten years?
What are the key unmet needs in the market?

𝐁𝐫𝐨𝐰𝐬𝐞 𝐭𝐡𝐞 𝐋𝐚𝐭𝐞𝐬𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭:

Nasopharyngeal Cancer Market Report 2023-2033:
https://www.imarcgroup.com/nasopharyngeal-cancer-market

Polycythemia Vera Market Report 2023-2033:
https://www.imarcgroup.com/polycythemia-vera-market

Preeclampsia Market Report 2023-2033:
https://www.imarcgroup.com/preeclampsia-market

Pulmonary Sarcoidosis Market Report 2023-2033: https://www.imarcgroup.com/pulmonary-sarcoidosis-market

Tardive Dyskinesia Market Report 2023-2033: https://www.imarcgroup.com/tardive-dyskinesia-market

Contact US

IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

About Us: -

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.